High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.

Heinzl N, Ghezelayagh TS, Wang G, Kohrn BF, Katz R, Coombes C, Smith TH, Norgaard ZK, Lo FY, Schmidt EK, Higgins JE, Valentine CC 3rd, Filipits M, Romanens L, Labidi-Galy I, Postl M, Grimm C, Cibula D, Dostálek L, Frühauf F, Jelenek G, Plch M, Fabian P, Mustea A, Condic M, Pristauz-Telsnigg G, Tamussino K, Bouda J, Brambs CE, O'Toole S, Bischof K, Grill S, Rosenthal AN, Vanderstichele A, Oppelt P, Rinda Soong T, Norquist BM, Salk JJ, Zeillinger R, Speiser P, Risques RA

Open source

DOI: 10.1038/s41698-026-01657-x
Published: 2026 Aug 29
Container: NPJ precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-026-01657-x,
  title = {High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.},
  author = {Heinzl N and Ghezelayagh TS and Wang G and Kohrn BF and Katz R and Coombes C and Smith TH and Norgaard ZK and Lo FY and Schmidt EK and Higgins JE and Valentine CC 3rd and Filipits M and Romanens L and Labidi-Galy I and Postl M and Grimm C and Cibula D and Dostálek L and Frühauf F and Jelenek G and Plch M and Fabian P and Mustea A and Condic M and Pristauz-Telsnigg G and Tamussino K and Bouda J and Brambs CE and O'Toole S and Bischof K and Grill S and Rosenthal AN and Vanderstichele A and Oppelt P and Rinda Soong T and Norquist BM and Salk JJ and Zeillinger R and Speiser P and Risques RA},
  year = {2026},
  journal = {NPJ precision oncology},
  doi = {10.1038/s41698-026-01657-x},
  url = {https://doi.org/10.1038/s41698-026-01657-x}
}

RIS

TY  - JOUR
TI  - High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.
AU  - Heinzl N
AU  - Ghezelayagh TS
AU  - Wang G
AU  - Kohrn BF
AU  - Katz R
AU  - Coombes C
AU  - Smith TH
AU  - Norgaard ZK
AU  - Lo FY
AU  - Schmidt EK
AU  - Higgins JE
AU  - Valentine CC 3rd
AU  - Filipits M
AU  - Romanens L
AU  - Labidi-Galy I
AU  - Postl M
AU  - Grimm C
AU  - Cibula D
AU  - Dostálek L
AU  - Frühauf F
AU  - Jelenek G
AU  - Plch M
AU  - Fabian P
AU  - Mustea A
AU  - Condic M
AU  - Pristauz-Telsnigg G
AU  - Tamussino K
AU  - Bouda J
AU  - Brambs CE
AU  - O'Toole S
AU  - Bischof K
AU  - Grill S
AU  - Rosenthal AN
AU  - Vanderstichele A
AU  - Oppelt P
AU  - Rinda Soong T
AU  - Norquist BM
AU  - Salk JJ
AU  - Zeillinger R
AU  - Speiser P
AU  - Risques RA
PY  - 2026
JO  - NPJ precision oncology
DO  - 10.1038/s41698-026-01657-x
UR  - https://doi.org/10.1038/s41698-026-01657-x
ER  -

APA

N, H., TS, G., G, W., BF, K., R, K., C, C., TH, S., ZK, N., FY, L., EK, S., JE, H., 3rd, V. C., M, F., L, R., I, L., M, P., C, G., D, C., L, D., F, F., G, J., M, P., P, F., A, M., M, C., G, P., K, T., J, B., CE, B., S, O., K, B., S, G., AN, R., A, V., P, O., T, R. S., BM, N., JJ, S., R, Z., P, S., & RA, R. (2026). High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.. NPJ precision oncology. https://doi.org/10.1038/s41698-026-01657-x

Source records

pubmed · retrieved 2026-09-27T01:32:33.934Z